The 46th annual meeting of the European society for blood and marrow transplantation: nurses group oral session (NO001-NO015) - Scorecard - MDSpire

The 46th annual meeting of the European society for blood and marrow transplantation: nurses group oral session (NO001-NO015)

  • December 11, 2020

  • 0 min

Share

Clinical Scorecard: Oral Presentations from the Nurses Group at the 46th Annual European Society for Blood and Marrow Transplantation Meeting (Sessions NO001-NO015)

At a Glance

CategoryDetail
ConditionAllogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Bone Marrow Aspirates (BMAs)
Key MechanismsSupport needs of family caregivers during allo-HSCT; pain and anxiety management during BMAs
Target PopulationFamily caregivers of allo-HSCT patients; patients undergoing BMAs in transplant programs
Care SettingTransplant centers and hematology units in Sweden and Italy

Key Highlights

  • Family caregivers of allo-HSCT patients report persistent unmet support needs related to information about the illness, future expectations, and emotional coping up to 16 weeks post-transplant.
  • Pain and anxiety during BMAs are significant concerns; local analgesia is universally used but sedation practices vary, especially between pediatric and adult centers in Italy.
  • Many Italian transplant centers lack standardized operating procedures (SOPs) for BMA pain management and do not provide adequate patient educational materials.

Guideline-Based Recommendations

Diagnosis

  • Assess family caregivers’ support needs longitudinally using validated tools such as the Carer Support Needs Assessment Tool (CSNAT).
  • Evaluate pain and anxiety levels associated with BMAs to tailor management strategies.

Management

  • Provide tailored interventions addressing family caregivers’ personal support needs prior to allo-HSCT to reduce strain.
  • Use local analgesia prior to BMAs consistently, respecting the onset time for effectiveness.
  • Implement sedation protocols especially in pediatric patients; consider sedation in adult patients based on individual needs and requests.
  • Offer informational and educational sessions to patients and caregivers before procedures.

Monitoring & Follow-up

  • Monitor family caregivers’ support needs over time, noting that some needs may persist or increase post-transplant.
  • Regularly assess pain and anxiety during BMAs to improve patient experience and adjust pain management protocols.

Risks

  • Inadequate pain control and anxiety management during BMAs can lead to increased patient distress and negative procedural memory.
  • Unmet support needs in family caregivers may contribute to psychological strain and reduced coping capacity.

Patient & Prescribing Data

Patients undergoing bone marrow aspirations in Italian transplant centers

Local analgesia is universally used but oral pain therapy before BMAs is rarely administered; sedation is standard in pediatric centers but underutilized in adult centers.

Clinical Best Practices

  • Use validated assessment tools like CSNAT to identify and address family caregivers’ support needs throughout the allo-HSCT trajectory.
  • Ensure local analgesia is administered with adequate time before BMAs to maximize pain relief.
  • Develop and implement SOPs for pain and anxiety management during BMAs across transplant centers.
  • Provide comprehensive patient and caregiver education about procedures and expected outcomes to reduce anxiety.
  • Consider sedation options tailored to patient age and preference to improve procedural comfort.

References

Original Source(s)

Related Content